Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 374

1.

Effects of the growth pattern of medulloblastoma on short-term neurological impairments after surgery: results from the prospective multicenter HIT-SIOP PNET 4 study.

Schepke E, Tisell M, Kennedy C, Puget S, Ferroli P, Chevignard M, Doz F, Pizer B, Rutkowski S, Massimino M, Navajas A, Schwalbe E, Hicks D, Clifford SC, Pietsch T, Lannering B.

J Neurosurg Pediatr. 2020 Jan 17:1-9. doi: 10.3171/2019.11.PEDS19349. [Epub ahead of print]

PMID:
31952041
2.

Radiological evaluation of newly diagnosed non-brainstem pediatric high-grade glioma in the HERBY phase II trial.

Rodriguez Gutierrez D, Jones C, Varlet P, Mackay A, Warren D, Warmuth-Metz M, Sánchez Aliaga E, Calmon R, Hargrave DR, Cañete A, Massimino M, Azizi AA, Le Deley MC, Saran F, Rousseau RF, Zahlmann G, Garcia J, Vassal G, Grill J, Morgan PS, Jaspan T.

Clin Cancer Res. 2020 Jan 10. pii: clincanres.3154.2019. doi: 10.1158/1078-0432.CCR-19-3154. [Epub ahead of print]

PMID:
31924736
3.

Retrospective analysis on the consistency of MRI features with histological and molecular markers in diffuse intrinsic pontine glioma (DIPG).

Giagnacovo M, Antonelli M, Biassoni V, Schiavello E, Warmuth-Metz M, Buttarelli FR, Modena P, Massimino M.

Childs Nerv Syst. 2019 Dec 17. doi: 10.1007/s00381-019-04463-y. [Epub ahead of print]

PMID:
31848724
4.

Effects of supratentorial and infratentorial tumor location on cognitive functioning of children with brain tumor.

Corti C, Urgesi C, Massimino M, Gandola L, Bardoni A, Poggi G.

Childs Nerv Syst. 2019 Dec 12. doi: 10.1007/s00381-019-04434-3. [Epub ahead of print]

PMID:
31832765
5.

Detection and Clinical Implications of a Novel BCR-ABL1 E12A2 Insertion/Deletion in a CML Patient Expressing the E13A2 Isoform.

Stella S, Massimino M, Tirrò E, Vitale SR, Accurso V, Puma A, Pennisi MS, DI Gregorio S, Romano C, DI Raimondo F, Siragusa S, Manzella L.

Anticancer Res. 2019 Dec;39(12):6965-6971. doi: 10.21873/anticanres.13918.

PMID:
31810968
6.

Short-term and long-term outcomes after preventive surgery in adolescent patients with familial adenomatous polyposis.

Vitellaro M, Piozzi G, Signoroni S, Ricci MT, Ciniselli CM, Cardani A, Vecchi I, Mancini A, Magarotto A, Verderio P, Massimino M, Ferrari A, Biasoni D.

Pediatr Blood Cancer. 2019 Dec 5:e28110. doi: 10.1002/pbc.28110. [Epub ahead of print]

PMID:
31802619
7.

Wilms tumor, medulloblastoma, and rhabdomyosarcoma in adult patients: lessons learned from the pediatric experience.

Spreafico F, Ferrari A, Mascarin M, Collini P, Morosi C, Biasoni D, Biassoni V, Schiavello E, Gandola L, Gattuso G, Chiaravalli S, Massimino M.

Cancer Metastasis Rev. 2019 Dec 3. doi: 10.1007/s10555-019-09831-3. [Epub ahead of print] Review.

PMID:
31797181
8.

MiRNAs as Players in Rhabdomyosarcoma Development.

Gasparini P, Ferrari A, Casanova M, Limido F, Massimino M, Sozzi G, Fortunato O.

Int J Mol Sci. 2019 Nov 19;20(22). pii: E5818. doi: 10.3390/ijms20225818. Review.

9.

Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma.

Suzuki H, Kumar SA, Shuai S, Diaz-Navarro A, Gutierrez-Fernandez A, De Antonellis P, Cavalli FMG, Juraschka K, Farooq H, Shibahara I, Vladoiu MC, Zhang J, Abeysundara N, Przelicki D, Skowron P, Gauer N, Luu B, Daniels C, Wu X, Forget A, Momin A, Wang J, Dong W, Kim SK, Grajkowska WA, Jouvet A, Fèvre-Montange M, Garrè ML, Nageswara Rao AA, Giannini C, Kros JM, French PJ, Jabado N, Ng HK, Poon WS, Eberhart CG, Pollack IF, Olson JM, Weiss WA, Kumabe T, López-Aguilar E, Lach B, Massimino M, Van Meir EG, Rubin JB, Vibhakar R, Chambless LB, Kijima N, Klekner A, Bognár L, Chan JA, Faria CC, Ragoussis J, Pfister SM, Goldenberg A, Wechsler-Reya RJ, Bailey SD, Garzia L, Morrissy AS, Marra MA, Huang X, Malkin D, Ayrault O, Ramaswamy V, Puente XS, Calarco JA, Stein L, Taylor MD.

Nature. 2019 Oct;574(7780):707-711. doi: 10.1038/s41586-019-1650-0. Epub 2019 Oct 9.

PMID:
31664194
10.

Where Are Adolescents with Soft Tissue Sarcomas Treated? An Italian Nationwide Study on Referrals Based on Hospital Discharge Records.

Ferrari A, Bernasconi A, Sironi G, Bergamaschi L, Botta L, Chiaravalli S, Casanova M, Bisogno G, Milano GM, Mascarin M, Tornesello A, Quarello P, Massimino M, Gatta G, Trama A.

J Adolesc Young Adult Oncol. 2019 Oct 29. doi: 10.1089/jayao.2019.0117. [Epub ahead of print]

PMID:
31660779
11.

ALS-Associated SOD1(G93A) Decreases SERCA Pump Levels and Increases Store-Operated Ca2+ Entry in Primary Spinal Cord Astrocytes from a Transgenic Mouse Model.

Norante RP, Peggion C, Rossi D, Martorana F, De Mario A, Lia A, Massimino ML, Bertoli A.

Int J Mol Sci. 2019 Oct 17;20(20). pii: E5151. doi: 10.3390/ijms20205151.

12.

Action observation therapy in pediatric patients with neuromotor deficits of the upper limbs secondary to central nervous system tumors.

Chisari M, Sensi R, Clerici CA, Gariboldi FA, Spreafico F, Biassoni V, Schiavello E, Gasparini P, Caraceni AT, Ferrari A, Massimino M.

Tumori. 2019 Dec;105(6):NP75-NP78. doi: 10.1177/0300891619880603. Epub 2019 Oct 10.

PMID:
31600120
13.

Recurrent non-coding U1-snRNA mutations drive cryptic splicing in Shh medulloblastoma.

Suzuki H, Kumar SA, Shuai S, Diaz-Navarro A, Gutierrez-Fernandez A, De Antonellis P, Cavalli FMG, Juraschka K, Farooq H, Shibahara I, Vladoiu MC, Zhang J, Abeysundara N, Przelicki D, Skowron P, Gauer N, Luu B, Daniels C, Wu X, Forget A, Momin A, Wang J, Dong W, Kim SK, Grajkowska WA, Jouvet A, Fèvre-Montange M, Garrè ML, Rao AAN, Giannini C, Kros JM, French PJ, Jabado N, Ng HK, Poon WS, Eberhart CG, Pollack IF, Olson JM, Weiss WA, Kumabe T, López-Aguilar E, Lach B, Massimino M, Van Meir EG, Rubin JB, Vibhakar R, Chambless LB, Kijima N, Klekner A, Bognár L, Chan JA, Faria CC, Ragoussis J, Pfister SM, Goldenberg A, Wechsler-Reya RJ, Bailey SD, Garzia L, Morrissy AS, Marra MA, Huang X, Malkin D, Ayrault O, Ramaswamy V, Puente XS, Calarco JA, Stein L, Taylor MD.

Nature. 2019 Oct 9. doi: 10.1038/s41586-019-1650-0. [Epub ahead of print]

PMID:
31597162
14.

Enzymatic labelling of snake venom phospholipase A2 toxins.

Spolaore B, Fernández J, Lomonte B, Massimino ML, Tonello F.

Toxicon. 2019 Dec;170:99-107. doi: 10.1016/j.toxicon.2019.09.019. Epub 2019 Sep 26.

PMID:
31563525
15.

The Link of the Prion Protein with Ca2+ Metabolism and ROS Production, and the Possible Implication in Aβ Toxicity.

De Mario A, Peggion C, Massimino ML, Norante RP, Zulian A, Bertoli A, Sorgato MC.

Int J Mol Sci. 2019 Sep 19;20(18). pii: E4640. doi: 10.3390/ijms20184640. Review.

16.

Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice.

Tirrò E, Martorana F, Romano C, Vitale SR, Motta G, Di Gregorio S, Massimino M, Pennisi MS, Stella S, Puma A, Gianì F, Russo M, Manzella L, Vigneri P.

Genes (Basel). 2019 Sep 13;10(9). pii: E709. doi: 10.3390/genes10090709. Review.

17.

Spirituality and Sustaining Hope in Adolescents with Cancer: The Patients' View.

Proserpio T, Pagani Bagliacca E, Sironi G, Clerici CA, Veneroni L, Massimino M, Ferrari A.

J Adolesc Young Adult Oncol. 2019 Sep 20. doi: 10.1089/jayao.2019.0058. [Epub ahead of print]

PMID:
31539288
18.

Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma.

Gasparini P, Fortunato O, De Cecco L, Casanova M, Iannó MF, Carenzo A, Centonze G, Milione M, Collini P, Boeri M, Dugo M, Gargiuli C, Mensah M, Segale M, Bergamaschi L, Chiaravalli S, Sensi ML, Massimino M, Sozzi G, Ferrari A.

Cancers (Basel). 2019 Sep 17;11(9). pii: E1380. doi: 10.3390/cancers11091380.

19.

Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?

El-Khouly FE, Veldhuijzen van Zanten SEM, Santa-Maria Lopez V, Hendrikse NH, Kaspers GJL, Loizos G, Sumerauer D, Nysom K, Pruunsild K, Pentikainen V, Thorarinsdottir HK, Rutkauskiene G, Calvagna V, Drogosiewicz M, Dragomir M, Deak L, Kitanovski L, von Bueren AO, Kebudi R, Slavc I, Jacobs S, Jadrijevic-Cvrlje F, Entz-Werle N, Grill J, Kattamis A, Hauser P, Pears J, Biassoni V, Massimino M, Lopez Aguilar E, Torsvik IK, Joao Gil-da-Costa M, Kumirova E, Cruz-Martinez O, Holm S, Bailey S, Hayden T, Thomale UW, Janssens GOR, Kramm CM, van Vuurden DG.

J Neurooncol. 2019 Oct;145(1):177-184. doi: 10.1007/s11060-019-03287-9. Epub 2019 Sep 14.

20.

Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose Imatinib.

Stella S, Tirró E, Massimino M, Vitale SR, Russo S, Pennisi MS, Puma A, Romano C, DI Gregorio S, Innao V, Stagno F, DI Raimondo F, Musolino C, Manzella L.

In Vivo. 2019 Sep-Oct;33(5):1593-1598. doi: 10.21873/invivo.11641.

21.

BCR-ABL1 Doubling-Times and Halving-Times May Predict CML Response to Tyrosine Kinase Inhibitors.

Pennisi MS, Stella S, Vitale SR, Puma A, Di Gregorio S, Romano C, Tirrò E, Massimino M, Antolino A, Siragusa S, Mannina D, Impera S, Musolino C, Mineo G, Martino B, Zammit V, Di Raimondo F, Manzella L, Stagno F, Vigneri P.

Front Oncol. 2019 Aug 13;9:764. doi: 10.3389/fonc.2019.00764. eCollection 2019.

22.

What Do We Know About the Do-It-Yourself Diets of Patients in Our Care?

Veneroni L, Rossi P, Della Valle S, Gavazzi C, Meazza C, Clerici CA, Ferrari A, Massimino M.

J Pediatr Hematol Oncol. 2019 Jul 26. doi: 10.1097/MPH.0000000000001562. [Epub ahead of print]

PMID:
31449499
23.

Medulloblastoma and central nervous system germ cell tumors in adults: is pediatric experience applicable?

Mascarin M, Coassin E, Franceschi E, Gandola L, Carrabba G, Brandes AA, Massimino M.

Childs Nerv Syst. 2019 Dec;35(12):2279-2287. doi: 10.1007/s00381-019-04340-8. Epub 2019 Aug 14. Review.

PMID:
31414168
24.

Rapid decline of Philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report.

Massimino M, Stella S, Tirrò E, Consoli ML, Pennisi MS, Puma A, Vitale SR, Romano C, Zammit V, Stagno F, Di Raimondo F, Manzella L.

Oncol Lett. 2019 Sep;18(3):2648-2653. doi: 10.3892/ol.2019.10558. Epub 2019 Jul 4.

25.

Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment.

Manzella L, Massimino M, Stella S, Tirrò E, Pennisi MS, Martorana F, Motta G, Vitale SR, Puma A, Romano C, Di Gregorio S, Russo M, Malandrino P, Vigneri P.

Int J Mol Sci. 2019 Jul 2;20(13). pii: E3258. doi: 10.3390/ijms20133258. Review.

26.

Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report.

Massimino M, Stella S, Tirrò E, Consoli ML, Pennisi MS, Puma A, Vitale SR, Romano C, Zammit V, Stagno F, DI Raimondo F, Manzella L.

Anticancer Res. 2019 Jul;39(7):3949-3954. doi: 10.21873/anticanres.13548.

PMID:
31262926
27.

Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22).

Tirrò E, Massimino M, Stella S, Zammit V, Consoli ML, Pennisi MS, Vitale SR, Romano C, Pirosa MC, Martino E, DI Gregorio S, Puma A, DI Raimondo F, Manzella L, Stagno F.

Anticancer Res. 2019 Jul;39(7):3893-3899. doi: 10.21873/anticanres.13540.

PMID:
31262918
28.

The European Society of Paediatric Oncology Ependymoma-II program Core-Plus model: Development and initial implementation of a cognitive test protocol for an international brain tumour trial.

Thomas S, Reynolds D, Morrall MCHJ, Limond J, Chevignard M, Calaminus G, Poggi G, Bennett E, Frappaz D, Slade D, Gautier J, McQuilton P, Massimino M, Grundy R.

Eur J Paediatr Neurol. 2019 Jul;23(4):560-570. doi: 10.1016/j.ejpn.2019.05.009. Epub 2019 May 18.

PMID:
31182404
29.

Loop: there's no going back: A Graphic Novel by Adolescent Cancer Patients on the Youth Project in Milan.

Ferrari A, Veneroni L, Signoroni S, Silva M, Gaggiotti P, Casanova M, Chiaravalli S, Clerici CA, Proserpio T, Massimino M.

J Med Humanit. 2019 Dec;40(4):505-511. doi: 10.1007/s10912-019-09561-1.

PMID:
31165370
30.

Sport activities and exercise as part of routine cancer care in children and adolescents.

Spreafico F, Murelli M, Timmons BW, Massimino M, Barr R.

Pediatr Blood Cancer. 2019 Aug;66(8):e27826. doi: 10.1002/pbc.27826. Epub 2019 May 21.

PMID:
31115152
31.

Rhabdomyosarcoma in adults: analysis of treatment modalities in a prospective single-center series.

Bergamaschi L, Bertulli R, Casanova M, Provenzano S, Chiaravalli S, Gasparini P, Collini P, Sangalli C, Gandola L, Diletto B, Morosi C, Fiore M, Massimino M, Ferrari A.

Med Oncol. 2019 May 18;36(7):59. doi: 10.1007/s12032-019-1282-0.

PMID:
31104202
32.

Spiritual support: A model of care not to forget.

Proserpio T, Ferrari A, Clerici CA, Massimino M.

Pediatr Blood Cancer. 2019 Oct;66(10):e27818. doi: 10.1002/pbc.27818. Epub 2019 May 14. No abstract available.

PMID:
31087623
33.

Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib.

Stella S, Zammit V, Vitale SR, Pennisi MS, Massimino M, Tirrò E, Forte S, Spitaleri A, Antolino A, Siracusa S, Accurso V, Mannina D, Impera S, Musolino C, Russo S, Malato A, Mineo G, Musso M, Porretto F, Martino B, Di Raimondo F, Manzella L, Vigneri P, Stagno F.

Int J Mol Sci. 2019 May 6;20(9). pii: E2226. doi: 10.3390/ijms20092226.

34.

A dedicated cloud system for real-time upfront quality assurance in pediatric radiation therapy.

Meroni S, Cavatorta C, Barra S, Cavagnetto F, Scarzello G, Scaggion A, Pecori E, Diletto B, Alessandro O, Massimino M, Gianolini S, Pignoli E, Gandola L.

Strahlenther Onkol. 2019 Sep;195(9):843-850. doi: 10.1007/s00066-019-01469-y. Epub 2019 Apr 25.

PMID:
31025053
35.

Diary of a journey to a faraway galaxy.

Ferrari A, Veneroni L, Romani A, Pagani Bagliacca E, Gaggiotti P, Silva M, Signoroni S, Massimino M.

Tumori. 2019 Dec;105(6):NP32-NP34. doi: 10.1177/0300891619844326. Epub 2019 Apr 26.

PMID:
31023193
36.

[Continuity and school reentry support of patients with serious diseases: experiences in pediatric oncology.]

Giovanetti M, Clerici CA, Veneroni L, Casiraghi G, Pagani Bagliacca E, Ferrari A, Podda M, Chopard S, Massimino M.

Recenti Prog Med. 2019 Mar;110(3):131-137. doi: 10.1701/3132.31140. Review. Italian.

PMID:
30968853
37.

Colony-Forming Cell Assay Detecting the Co-Expression of JAK2V617F and BCR-ABL1 in the Same Clone: A Case Report.

Tirrò E, Stella S, Massimino M, Zammit V, Pennisi MS, Vitale SR, Romano C, Di Gregorio S, Puma A, Di Raimondo F, Stagno F, Manzella L.

Acta Haematol. 2019;141(4):261-267. doi: 10.1159/000496821. Epub 2019 Apr 9.

PMID:
30965317
38.

Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53.

Tirrò E, Massimino M, Romano C, Pennisi MS, Stella S, Vitale SR, Fidilio A, Manzella L, Parrinello NL, Stagno F, Palumbo GA, La Cava P, Romano A, Di Raimondo F, Vigneri PG.

Front Oncol. 2019 Feb 18;9:57. doi: 10.3389/fonc.2019.00057. eCollection 2019.

39.

Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood.

Minasi S, Baldi C, Pietsch T, Donofrio V, Pollo B, Antonelli M, Massimino M, Giangaspero F, Buttarelli FR.

J Neurooncol. 2019 May;142(3):435-444. doi: 10.1007/s11060-019-03127-w. Epub 2019 Mar 4.

PMID:
30830680
40.

Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study.

Fleischhack G, Massimino M, Warmuth-Metz M, Khuhlaeva E, Janssen G, Graf N, Rutkowski S, Beilken A, Schmid I, Biassoni V, Gorelishev SK, Kramm C, Reinhard H, Schlegel PG, Kortmann RD, Reuter D, Bach F, Iznaga-Escobar NE, Bode U.

J Neurooncol. 2019 May;143(1):107-113. doi: 10.1007/s11060-019-03140-z. Epub 2019 Mar 4.

PMID:
30830679
41.

Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors.

Ferrari A, Brecht IB, Gatta G, Schneider DT, Orbach D, Cecchetto G, Godzinski J, Reguerre Y, Bien E, Stachowicz-Stencel T, Ost M, Magni C, Kearns P, Vassal G, Massimino M, Biondi A, Bisogno G, Trama A.

Eur J Cancer. 2019 Mar;110:120-126. doi: 10.1016/j.ejca.2018.12.031. Epub 2019 Feb 19.

PMID:
30785015
42.

Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960-1999 and registered in the Italian Off-Therapy Registry.

Bagnasco F, Caruso S, Andreano A, Valsecchi MG, Jankovic M, Biondi A, Miligi L, Casella C, Terenziani M, Massimino M, Sacerdote C, Morsellino V, Erminio G, Garaventa A, Faraci M, Micalizzi C, Garrè ML, Pillon M, Basso G, Biasin E, Fagioli F, Rondelli R, Pession A, Locatelli F, Santoro N, Indolfi P, Palumbo G, Russo G, Verzegnassi F, Favre C, Zecca M, Mura R, D'Angelo P, Cano C, Byrne J, Haupt R; OTR-AIEOP Registry.

Eur J Cancer. 2019 Mar;110:86-97. doi: 10.1016/j.ejca.2018.12.021. Epub 2019 Feb 14.

PMID:
30772657
43.

"Summer is you": Adolescents and young adults with cancer sing about their desire for summer.

Signoroni S, Veneroni L, Pagani Bagliacca E, Gaggiotti P, Silva M, Casanova M, Chiaravalli S, Clerici CA, Massimino M, Ferrari A.

Pediatr Blood Cancer. 2019 May;66(5):e27630. doi: 10.1002/pbc.27630. Epub 2019 Jan 24.

PMID:
30677216
44.

Single cell analysis reveals the involvement of the long non-coding RNA Pvt1 in the modulation of muscle atrophy and mitochondrial network.

Alessio E, Buson L, Chemello F, Peggion C, Grespi F, Martini P, Massimino ML, Pacchioni B, Millino C, Romualdi C, Bertoli A, Scorrano L, Lanfranchi G, Cagnin S.

Nucleic Acids Res. 2019 Feb 28;47(4):1653-1670. doi: 10.1093/nar/gkz007.

45.

Safety and efficacy of Endoscopic Third Ventriculostomy in Diffuse Intrinsic Pontine Glioma related hydrocephalus: a Systematic Review.

Guida L, Roux FE, Massimino M, Marras CE, Sganzerla E, Giussani C.

World Neurosurg. 2018 Dec 29. pii: S1878-8750(18)32919-X. doi: 10.1016/j.wneu.2018.12.096. [Epub ahead of print] Review.

PMID:
30599251
46.

B-ALL Relapses After Autologous Stem Cell Transplantation Associated With a Shift from e1a2 to e14a2 BCR-ABL Transcripts: A Case Report.

Stella S, Massimino M, Tirrò E, Vitale SR, Scalise L, Leotta S, Pennisi MS, Puma A, Romano C, Stagno F, Sapienza G, Milone G, Manzella L.

Anticancer Res. 2019 Jan;39(1):431-435. doi: 10.21873/anticanres.13130.

PMID:
30591491
47.

Effect of Combined Epigenetic Treatments and Ectopic NIS Expression on Undifferentiated Thyroid Cancer Cells.

Massimino M, Tirrò E, Stella S, Frasca F, Vella V, Sciacca L, Pennisi MS, Vitale SR, Puma A, Romano C, Manzella L.

Anticancer Res. 2018 Dec;38(12):6653-6662. doi: 10.21873/anticanres.13032.

PMID:
30504373
48.

Visual perception and spatial transformation of the body in children and adolescents with brain tumor.

Corti C, Poggi G, Massimino M, Bardoni A, Borgatti R, Urgesi C.

Neuropsychologia. 2018 Nov;120:124-136. doi: 10.1016/j.neuropsychologia.2018.10.012. Epub 2018 Oct 22.

PMID:
30359652
49.

From the seventh floor to seventh heaven.

Veneroni L, Gaggiotti P, Ciceri D, Rosati E, Massimino M, Ferrari A.

Tumori. 2019 Dec;105(6):529-530. doi: 10.1177/0300891618805655. Epub 2018 Oct 24. No abstract available.

PMID:
30352536
50.

Cognitive functioning of pediatric patients with brain tumor: an investigation of the role of gender.

Corti C, Manfredi V, Massimino M, Bardoni A, Borgatti R, Poggi G.

Childs Nerv Syst. 2018 Dec;34(12):2415-2423. doi: 10.1007/s00381-018-3982-8. Epub 2018 Oct 1.

PMID:
30276651

Supplemental Content

Loading ...
Support Center